PATENT CLAIM ANALYSIS

Application Number: 15747153
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "04400A"]

Abstract:
The present invention is directed to anti-sense microRNA-328 in a form of oligodeoxyribonucleotides, or locked nucleic acid (LNA)-modified, and phosphorothioated (PS) bond-modified oligonucleotides. The present invention is also directed to a pharmaceutical composition comprising the anti-sense microRNA-328 composition and a pharmaceutically acceptable carrier. The present invention is further directed to a method for preventing or treating myopia by administering to a subject the anti-sense microRNA-328 composition. A preferred route of administration is topical administration to the eyes.

Claim (Index 1):
A deoxyribonucleotide sequence of SEQ ID NO: 3 or SEQ ID NO: 4.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 86.0
- Lexical Diversity: 1.72549
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14674786', '12936732', '13921537', '14898033', '14527115']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7381489984791143
- 35 USC 102 Novelty (BERT): 0.5041643575985659
- Combined Prediction Score: 0.7147505343910594
- Mean Citation Score: 142.06742
- Max Citation Score: 156.61781000000005
- Similarity Product: 87.33675016290489

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test